OVERVIEW

Vilon 20mg (Bioregulator) is a synthetic peptide belonging to the cytomedine class of organ-specific bioregulators. It is composed of a short amino acid sequence—typically lysine and glutamic acid—designed to support thymus gland function. The thymus plays a central role in immune system development and regulation, particularly in the maturation of T-lymphocytes. Vilon is studied for its potential to help normalize immune responses by influencing gene expression and protein synthesis within thymic cells. Through this mechanism, it may contribute to maintaining immune balance, especially during aging, stress, or periods of immune suppression.

At a 20mg dosage, Vilon is commonly supplied in capsule or peptide form for research or specialized use. Experimental studies suggest it may help support immune resilience, improve adaptive immune responses, and promote overall cellular stability within the immune system. Because thymic activity naturally declines with age, bioregulators like Vilon are often explored for their potential role in age-related immune support. While generally considered well tolerated in research settings, large-scale international clinical trials remain limited. Vilon is not widely approved by major regulatory authorities as a prescription medication, and its use is typically confined to research or specialized frameworks. Professional guidance is recommended for appropriate dosing, administration, and monitoring.